AZT/3TC Opposition

GSK had filed in patent application for fixed dose combination of Zidovudine/Lamivudine (AZT/3TC) in 1997. Click here to view the Complete Specifications of this Application.

Here is the Pre-Grant Opposition filed by PLHIV Community

Pre-Grant Opposition to AZT_3TC fixed dose combination Application No. 2044/CAL/1997

This opposition resulted in withdrawal of the application by GSK. Access here: Open Letter from GSK promising withdrawal of AZT/3TC FDC

Also view the Letter from Patent Office declaring the withdrawal of GSK application.

TD Opposition and rejection order

View here pre-grant opposition to Tenofovir Disoproxil by PLHIV Community in India and Brazilian Civil society

India - Pre Grant Opposition by PLHIV networks to TD Application 2076/Del/1997 in 2006

India - Pre Grant Opposition by Brazilian organization and NGO Sahara to TD Application 2076/DEL/1997 in 2007

Also available here is the Rejection of TD application by Indian Patent Office

Patent RejectionOrder to TD 2076/DEL/1997 in 2009

TDF opposition

For anyone who is interested in looking at TDF opposition application and patent status:

Click here to see the India - Opposition to Tenofovir Disoproxil Fumarate (TDF) application

896/DEL/2002

Access here the Patent Rejection Order on TDF (896/DEL/2002) in India